Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 32 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	A Pharmacokinetic Study of Actinomycin-D and Vincristine in Children With Cancer				Phase IV				PPRU 10762 NCT00491946
	Donor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Allogeneic Transplantation				Phase II, Phase I				FHCRC-1803.00 NCT00068718
	Reduced Intensity Transplant Using Extracorporeal Photopheresis				Phase II, Phase I				ECP RIT NCT00179790
	Study Of CP-751,871 In Patients With Ewing's Sarcoma Family Of Tumors				Phase II, Phase I				A4021020 NCT00560235
	Monoclonal Antibody IMC-A12 and Doxorubicin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma				Phase II, Phase I				UCCRC-16227A 16227A, 8131, NCT00720174
	Chemotherapy Followed by Donor Peripheral Stem Cell Transplantation in Treating Young Patients With Recurrent Sarcoma				Phase II				NCI-02-C-0259H NCT00047372
	Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases				Phase II				PSCI-2003-232 NCT00084695
	Radiation Therapy to Treat Musculoskeletal Tumors				Phase II				RTSARC NCT00186992
	A Pilot Study of Tumor Cell Vaccine for High-Risk Solid Tumor Patients Following Stem Cell Transplantation				Phase II				UMCC 2005.050 GCRC ID # 2191, NCT00405327
	Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer				Phase II				MSKCC-05122 NCT00445965


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute